http://www.PR.com/ Latest news releases from PR.com for curasan AG. Tue, 14 Feb 2012 16:25:51 -0500 © 2012 PR Worldwide, Inc. 60 en-us http://www.PR.com/images/logo_white.jpg http://www.PR.com/ 68 69 PR.com provides Free Press Release Distribution, & is a unique Directory of Businesses, Products, Services, & Jobs - in all industries. Find Full Company Profiles. http://www.pr.com/press-release/341387 Wed, 27 Jul 2011 03:00:00 -0400 curasan AG, listed in the General Standard of the German Stock Exchange, has signed an agreement which provides Zimmer Dental Inc, Carlsbad, CA, (USA) with exclusive global distribution rights. [PR.com] http://www.pr.com/press-release/341387 curasan AG http://www.pr.com/press-release/319019 Sat, 07 May 2011 03:00:00 -0400 curasan AG has received FDA certification for its new granular bone regeneration material Ceracell® Dental [PR.com] http://www.pr.com/press-release/319019 curasan AG http://www.pr.com/press-release/309298 Wed, 30 Mar 2011 03:00:00 -0400 curasan AG has received European approval for a novel synthetic bone regeneration material. [PR.com] http://www.pr.com/press-release/309298 curasan AG http://www.pr.com/press-release/297435 Sat, 12 Feb 2011 03:00:00 -0500 curasan AG has received FDA certification and, therefore, marketing authorization throughout the USA of the synthetic bone replacement material Osbone® Dental which already has been authorized in the EU as Osbone®. [PR.com] http://www.pr.com/press-release/297435 curasan AG http://www.pr.com/press-release/297127 Fri, 11 Feb 2011 03:00:00 -0500 curasan AG has signed an agreement with Stryker S.A., Montreux, Switzerland, to sell and market bone replacement and regeneration materials for different orthopedic indications [PR.com] http://www.pr.com/press-release/297127 curasan AG http://www.pr.com/press-release/289778 Thu, 13 Jan 2011 03:00:00 -0500 curasan Inc., the north American subsidiary of exchange listed curasan AG, Germany, (ISIN: DE 000 549 453 8), has signed an exclusive supply agreement with TransCorp Spine Inc., Michigan, USA, for Cerasorb® Ortho block forms used to repair vertebral bone channels created during surgeries to decompress neural tissue in the spine. These block forms may be used in conjunction with surgical technique and an instrument [PR.com] http://www.pr.com/press-release/289778 curasan AG http://www.pr.com/press-release/278305 Sat, 20 Nov 2010 03:00:00 -0500 curasan AG has received the certification for the synthetic bone regeneration material Cerasorb® M ORTHO from the Canadian authorities, Health Canada. [PR.com] http://www.pr.com/press-release/278305 curasan AG http://www.pr.com/press-release/271642 Sat, 23 Oct 2010 03:00:00 -0400 curasan AG has received European approval for its new granular bone regeneration material Ceracell® [PR.com] http://www.pr.com/press-release/271642 curasan AG http://www.pr.com/press-release/267089 Wed, 06 Oct 2010 03:00:00 -0400 curasan AG expects to make a considerable profit instead of the two million euro loss announced for the financial year 2010. [PR.com] http://www.pr.com/press-release/267089 curasan AG http://www.pr.com/press-release/251644 Thu, 29 Jul 2010 03:00:00 -0400 Supporting wound healing and tissue regeneration through the extraction of autologous platelet-mediator-concentrate (PMC) – high patient compatibility using autologous blood – No need for centrifuges and external laboratories. [PR.com] http://www.pr.com/press-release/251644 curasan AG http://www.pr.com/press-release/237070 Thu, 27 May 2010 03:00:00 -0400 curasan AG has concluded a contract with Matricel GmbH, Herzogenrath, which secures exclusive rights for both companies over a jointly developed new product line. [PR.com] http://www.pr.com/press-release/237070 curasan AG http://www.pr.com/press-release/232484 Sat, 08 May 2010 03:00:00 -0400 curasan AG, listed in the General Standard of the German Stock Exchange (ISIN: DE 000 549 453 8), was able to achieve an annual surplus of 0.2 million Euro in the fiscal year 2009. The performance per share amounted to 0.03 Euro. “We had originally expected a slight negative performance for 2009 due to the product offensive introduced in autumn. Therefore, it is all the more satisfying for us that we were in fact [PR.com] http://www.pr.com/press-release/232484 curasan AG http://www.pr.com/press-release/220228 Thu, 18 Mar 2010 03:00:00 -0400 In Germany alone, every year about 800,000 tooth implants are placed. In the case of almost every second patient bone augmentation is necessary, because the jawbone atrophy is already too advanced. The development of bone substitute materials has advanced considerably over the last few years, particularly in the area of scaffold substances. There is a broad spectrum ranging from autologous, fully synthetic to xenogenic [PR.com] http://www.pr.com/press-release/220228 curasan AG http://www.pr.com/press-release/213969 Sat, 20 Feb 2010 03:00:00 -0500 curasan AG, listed in the General Standard of the Deutsche Börse AG, is commencing the sale, through a subsidiary, of its synthetic bone regeneration material Cerasorb® M Ortho in the United States. [PR.com] http://www.pr.com/press-release/213969 curasan AG http://www.pr.com/press-release/199464 Wed, 16 Dec 2009 03:00:00 -0500 A new study was presented at the 4th Annual Congress of the German Spine Society in Munich – it demonstrated the long-term effect of Curavisc® in the treatment of chronic facet syndrome [PR.com] http://www.pr.com/press-release/199464 curasan AG http://www.pr.com/press-release/198857 Sat, 12 Dec 2009 03:00:00 -0500 curasan AG has received CE certification and, therefore, marketing authorization throughout Europe of the synthetic bone replacement material Osbone®. [PR.com] http://www.pr.com/press-release/198857 curasan AG http://www.pr.com/press-release/193812 Thu, 19 Nov 2009 03:00:00 -0500 curasan AG, which is listed on the General Standard of the German Stock Exchange, has signed a research and development agreement with the Ben-Gurion University of the Negev (BGU), Israel. [PR.com] http://www.pr.com/press-release/193812 curasan AG http://www.pr.com/press-release/186482 Sun, 18 Oct 2009 03:00:00 -0400 curasan AG has received CE certification and, therefore, marketing authorization for the ATR® (Advanced Tissue Regeneration) product. [PR.com] http://www.pr.com/press-release/186482 curasan AG http://www.pr.com/press-release/185200 Wed, 14 Oct 2009 03:00:00 -0400 curasan AG is to invest in its future growth by implementing a technological investment programme amounting to approximately 1 million euros, despite the current crisis in the financial markets [PR.com] http://www.pr.com/press-release/185200 curasan AG http://www.pr.com/press-release/178638 Wed, 16 Sep 2009 03:00:00 -0400 curasan AG, listed on the General Standard of Deutsche Börse AG as ISIN: DE 000 549 453 8, has just received a grant of €1.48 million from the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) for a bone regeneration research project scheduled to last three years. The funds are earmarked for a joint project with Ben Gurion University (BGU) of the Negev, [PR.com] http://www.pr.com/press-release/178638 curasan AG